International Agency for Research on Cancer, WHO. Globocan
2012: estimated cancer incidence, mortality, and prevalence
worldwide in 2018....
Podlipnik S, Carrera C, Boada A, et al. Incidence of melanoma
in Catalonia, Spain, is rapidly increasing in the elderly
population. A multicentric...
Feld E, Mitchell TC. Immunotherapy in melanoma. Immunotherapy. 2018;10(11):987–998. https://doi.org/10.2217/imt-2017-
0143.
Coit DG, Thompson JA, Albertini AR, et al. Cutaneous
melanoma, version 2.2019, the NCCN clinical practice guidelines in oncology. J Natl Compr...
Swetter SM, Tsao H, Bichakjian CK, et al. Guidelines of care for
the management of primary cutaneous melanoma. J Am Acad
Dermatol. 2019;80(1):208–250....
Garbe C, Amaral T, Peris K, et al. European consensus-based
interdisciplinary guideline for melanoma. Part 1: diagnostics –
update 2019. Eur...
Joseph RW, Elassaiss-Schaap J, Kefford R, et al. Baseline tumor
size is an independent prognostic factor for overall survival in
patients...
Luke JJ, Flaherty KT, Ribas A, Long GV. Targeted agents and
immunotherapies: optimizing outcomes in melanoma. Nat
Rev Clin Oncol. 2017;14(8):463–482....
Huang AC, Postow MA, Orlowski RJ, et al. T-cell invigoration to
tumour burden ratio associated with anti-PD-1 response.
Nature. 2017;545(7652):60–65....
Riquelme-Mc Loughlin C, Podlipnik S, Bosch-Amate X, et al.
Diagnostic accuracy of imaging studies for initial staging of
T2b to T4b melanoma...
Barreiro-Capurro A, Andrés-Lencina JJ, Podlipnik S, et al.
Differences in cutaneous melanoma survival between the 7th
and 8th edition of the...
Leiter U, Buettner PG, Eigentler TK, et al. Hazard rates for
recurrent and secondary cutaneous melanoma: an analysis of
33,384 patients in...
Schramm S-J, Mann GJ. Melanoma prognosis: a REMARKbased systematic review and bioinformatic analysis of immunohistochemical and gene microarray...
Gould Rothberg BE, Bracken MB, Rimm DL. Tissue biomarkers
for prognosis in cutaneous melanoma: a systematic review
and meta-analysis. J Natl...
Kurtz J, Beasley GM, Agnese D, et al. Surveillance strategies in
the follow-up of melanoma patients: too much or not enough?
J Surg Res. 2017;214:32–37....
Garbe C, Schadendorf D. Surveillance and follow-up examinations in cutaneous melanoma. Onkologie. 2003;26(3):
241–246. https://doi.org/10.1159/000071619.
Podlipnik S, Carrera C, Sánchez M, et al. Performance of
diagnostic tests in an intensive follow-up protocol for patients
with American Joint...
Podlipnik S, Moreno-Ramírez D, Carrera C, et al. Costeffectiveness analysis of imaging strategy for an intensive
follow-up of patients with...
McEvoy AC, Pereira MR, Reid A, et al. Monitoring melanoma
recurrence with circulating tumor DNA: a proof of concept
from three case studies....
Ibrahim AM, Le May M, Bossé D, et al. Imaging intensity and
survival outcomes in High-Risk resected melanoma treated by
systemic therapy at...
Naeser Y, Helgadottir H, Brandberg Y, et al. TRIM study
protocol - a prospective randomized multicenter trial to
assess the role of imaging...
